Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare Biotechnology
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd > The Price is Down Because No one Cares About FSD
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(194)
•••
Post by Pyritetrapon Oct 28, 2021 5:33pm
181 Views
Post# 34060887

The Price is Down Because No one Cares About FSD

The Price is Down Because No one Cares About FSD

The Price is Down Because No one Cares About FSD

 

 

“With news that FSD Pharma, a Nasdaq listed company is getting involved in psychedelics I thought there might be at least some excitement, maybe some investors who weren’t around in the cannabis days. The general consensus from what I have seen is to stay away at all costs unless something fundamentally shifts, there are other more qualified and better run companies out there. FSD Pharma has been a gong show since its inception.”

 

https://equity.guru/2021/09/20/no-one-is-excited-about-fsd-pharma-huge-n-getting-into-psychedelics/

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities